IL-1α-induced activation of Ras and downstream ERK pathway can be inhibited by using inhibitory antibodies against α6 and β1 integrin and uPAR, consistent with the inhibition of proliferation, adhesion and migration of pancreatic cancer cells. This evidence concerns the gene PLAUR and familial pancreatic carcinoma.